138 related articles for article (PubMed ID: 11315254)
1. Gastric adenocarcinoma: pathomorphology and molecular pathology.
Werner M; Becker KF; Keller G; Höfler H
J Cancer Res Clin Oncol; 2001 Apr; 127(4):207-16. PubMed ID: 11315254
[TBL] [Abstract][Full Text] [Related]
2. The use of molecular biology in diagnosis and prognosis of gastric cancer.
Becker KF; Keller G; Hoefler H
Surg Oncol; 2000 Jul; 9(1):5-11. PubMed ID: 11525306
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of carcinogenesis in gastric cancer.
Höfler H; Becker KF
Recent Results Cancer Res; 2003; 162():65-72. PubMed ID: 12790321
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
5. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
6. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
7. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
8. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics of eight gastric cancer cell lines established in Japan.
Yokozaki H
Pathol Int; 2000 Oct; 50(10):767-77. PubMed ID: 11107048
[TBL] [Abstract][Full Text] [Related]
10. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
Zhang J; Guo L; Liu X; Li W; Ying J
Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
[TBL] [Abstract][Full Text] [Related]
11. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of gastric cancer.
Tahara E
World J Surg; 1995; 19(4):484-8; discussion 489-90. PubMed ID: 7676688
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
[TBL] [Abstract][Full Text] [Related]
15. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis.
Kountouras J; Zavos C; Chatzopoulos D; Katsinelos P
J Surg Res; 2008 May; 146(1):149-58. PubMed ID: 17720195
[TBL] [Abstract][Full Text] [Related]
16. Cysteine and serine proteases in gastric cancer.
Plebani M; Herszènyi L; Cardin R; Roveroni G; Carraro P; Paoli MD; Rugge M; Grigioni WF; Nitti D; Naccarato R
Cancer; 1995 Aug; 76(3):367-75. PubMed ID: 8625115
[TBL] [Abstract][Full Text] [Related]
17. High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma.
Cho JY; Chung HC; Noh SH; Roh JK; Min JS; Kim BS
Cancer; 1997 Mar; 79(5):878-83. PubMed ID: 9041148
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.
Heiss MM; Babic R; Allgayer H; Gruetzner KU; Jauch KW; Loehrs U; Schildberg FW
J Clin Oncol; 1995 Aug; 13(8):2084-93. PubMed ID: 7636552
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.
Ottenhof NA; de Wilde RF; Morsink FH; de Leng WW; Ausems MG; Morreau H; van Hillegersberg R; Offerhaus GJ; Milne AN
Hum Pathol; 2012 Mar; 43(3):457-61. PubMed ID: 21992816
[TBL] [Abstract][Full Text] [Related]
20. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.
Lee JH; Abraham SC; Kim HS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Rashid A; Hamilton SR; Wu TT
Am J Pathol; 2002 Aug; 161(2):611-8. PubMed ID: 12163385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
